OPPORTUNITY ANALYSIS OF H1N1 (SWINE FLU) VACCINE MARKET

Transcription

1 OPPORTUNITY ANALYSIS OF H1N1 (SWINE FLU) VACCINE MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a r k e t s MarketsandMarkets Research 108 West 13th Street, Wilmington, DE 19801, County of New Castle Tel. No.:

2 Report Description Key Take-Aways To define and analyze the forecasts of the global H1N1 influenza vaccines market. To identify the major market opportunities, drivers, and inhibitors of the global H1N1 influenza vaccines market. To identify the major stakeholders in the market and draw a competitive landscape for the market leaders. Report Description The H1N1 Influenza A (2009) pandemic has affected more than 0.4 million people in 180 countries across the globe. The alphabets H and N are designated for the proteins Hemagglutinin and Neuraminidase present on the surface area of the virus. The flu, first began in Mexico in March 2009, and then affected the U.S., after which it spread across the globe. The H1N1/09 virus has genetic elements originating from avian, swine, and human sources, making it far more fatal than the 1918 H1N1 (Spanish Flu) outbreak. The overall H1N1 vaccines market is classified into the intramuscular and intranasal vaccines submarkets, of which the former holds the major share. The first movers are GlaxoSmithKline (GSK), Novartis, Commonwealth Serum Laboratories (CSL), Medimmune, Baxter, Sinovac, and Sanofi Pastuer. These companies have received approvals from various governments, including those of the U.S., the U.K., France, China, Denmark, and Australia. The U.S.-based Medimmune is currently the only manufacturer of the intranasal vaccine. Curative drugs such as Tamiflu were introduced in the initial phase of the H1N1 pandemic, while the latter phase is expected to Governmental involvement and the increased awareness necessitate the introduction of vaccines facilitating prevention about the pandemic is driving the growth of the H1N1 vaccines rather than the cure. This market research report forecasts the market; thus encouraging market players to gain a better H1N1 vaccine market for disease prevention in the unaffected understanding of the market dynamics, technological population. The initial lot of vaccines will be egg-based and innovations, product pricing, marketing, and regulatory cell-based and first administered to the priority groups such as framework. The global H1N1 influenza vaccine market is pregnant women, chronic disease patients, and children above expected to be $676 million in The market is expected to 6 months of age. These vaccines were launched in Australia in show a high CAGR of 222.4% from 2009 to 2011; but as most of October the global population is expected to be immunized by the end of 2011, a more moderate growth is expected in the future 2

3 Report Description Scope of the Report This report will enable strategic understanding of the opportunities in the H1N influenza vaccines market. Each section of the report offers market data as per the products (intramuscular and intranasal vaccines), and as per the geographies (North America, Europe, Asia-Pacific, and ROW). It also provides market trends with respect to drivers, restraints, and opportunities. The report s strategic section draws a competitive landscape of the global H1N1 vaccines market with 24 company profiles. Stakeholders The intended audience of this report includes: Pharmaceutical companies Researchers Government institutions 3

4 Table of Contents Executive Summary 1. Market overview 2. Global H1N influenza vaccine market, by products 3. Global H1N influenza vaccine market, by geography 4. Competitive scenario 1. Introduction 1.1 Key Take-aways 1.2 Report Description 1.3 Scope of The Report 1.4 Stakeholders 2. Summary 2.1 Research Methodology 3. Market Overview Spanish Influenza (H1N1) Pandemic Asian Flu (H2N2) Hongkong Flu H1N1 Influenza H1N1 pandemic cycle 4. Market Dynamics 4.1. Drivers & Restraints Restraints & opportunities Cost of H1N1 Vaccine 4.3. Pricing of H1N1 Vaccine Vaccine awareness 4.4. Consumer Insights Side-effects of vaccine Availability of substitute treatment 4.2. Market Forces Analysis Supply-side drivers Demand-side drivers 4

5 Table of Contents 5. Global H1N Influenza Vaccine Market 5.1. Market Overview 5.5. Intramuscular H1N1 Vaccine Market Priority groups for the H1N1 vaccine Drivers & restraints 5.2. Drivers & Restraints Caters to large population segment Public-private partnerships for supply of H1N Rates low on user-friendliness vaccine 5.6. Intranasal H1N1 Vaccine Government subsidies for vaccine manufacture Drivers & restraints Revenue-increasing source User-friendly administration High costs & lengthy manufacturing process Fewer side-effects & improved efficacy 5.3. Opportunities Insurance coverage Shift from egg-based to cell-based manufacturing Limited consumer segment Market for adjuvants Competitive Analysis Opportunity for emerging economies 5.7. Benchmarking of Approved Vaccine 5.4. Manufacturing Process of Influenza Vaccines Pipeline overview of H1N1 vaccine Egg-based manufacturing Cell-based manufacturing Recombinant technology 6. Geographical Analysis of Global H1N1 Vaccine Market 6.1. Moon Matrix Analysis of Global Asia Pacific H1N1 Vaccine Market H1N1 Influenza Vaccine, by Geography Australia Healthcare expenditure & government contracts China Spread of H1N1 & availability of H1N1 vaccine Japan 6.2. North American H1N1 Vaccine Market India Drivers & restraints 6.4. Rest of World (ROW) H1N1 Vaccine Market 6.3. Europe H1N1 Vaccine Market Drivers & restraints 7. Strategic Conclusion 5

6 Table of Contents 10. Company Profiles Baxter International Inc Medimmune Butantan Institute Merck & Co Cantacuzino Institute of Sera and Vaccines Novartis Changchun Institute of Biological Products Novavax Crucell N.V Omninvest CSL Panacea Biotec Denka Seiken Co Ltd Sanofi-pasteur Green Cross Corp Shanghai Institute of Biological Products Glaxosmithkline Plc Sinovac Biotech Ltd Hualan Biological Engineering Inc Serum Institute of India Ltd Inovio Biomedical Corp Solvay Kitasato Institute Zhejiang Tianyuan Bio-pharmaceutical Co, Ltd Appendix World H1N1 Influenza Cases in October 2009 Country Wise Death Rates by H1N1 Flu till October

7 List of Tables Summary Table Global Market for 2009 H1N1 Influenza Vaccine by Products ($Millions) 1 WHO-defined Levels of Influenza Pandemic 2 Global H1N Influenza Vaccine Market, by Products ($Millions) 3 Global H1N1 Influenza Vaccine Market, by Geography ($Millions) 4 Global Market for Intramuscular H1N1 Vaccines, by Geography ($Millions) 5 Government Intiatives for H1N1 Vaccine 6 Contracts for H1N1 Vaccine 7 Market Development for H1N1 Vaccine 8 Benchmarking of Vaccine 9 Technology & Delivery of Vaccine 10 H1N1 Vaccine Trials 11 North American Market for H1N1 Influenza Vaccine, ($Millions) 12 Asia Pacific Market for H1N1 Vaccine, ($Millions) List of Figures 1 Pandemic Wave Diagram Spanish Influenza 2 Spanish Flu Fatalities in The U.S. ( ) 3 Pandemic Scenario of Hong Kong Flu 4 Pandemic Influenza Cycle 5 H1n Influenza Vaccine Market Dynamics 6 Tier Pricing Model for H1N1 Vaccine 7 Consumer Perspective for H1N1 Vaccine Market 8 Product Lifecycle in H1N1 Vaccine Market 9 Recommended Priority Groups for 2009 H1N1 Influenza Vaccine 10 Timeline of Commercialization of H1N1 Vaccine 11 Contract Sharing of Companies (2009) 12 Global Scenario of Influenza Pandemic 13 Global H1N1 Influenza Vaccine Market, by Geography 14 Moon Matrix of H1N1 Vaccine Market, by Geography 7

8 Sample Tables Global Market for 2009 H1N1 Influenza Vaccine by Products ($Millions) Intramuscular Intranasal Total Sample Tables CAGR Global Market for Intramuscular H1N1 Vaccines, by Geography ($Millions) North America Europe Asia Row Total CAGR Sample Tables 8

9 Key Questions What Makes Our Report Unique? We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5. We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer. We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. Comprehensive market analysis for the following sectors: Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and superretailers, technology providers, and research and development (R&D) companies. Key Questions Answered Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders? What are market estimates and forecasts; which markets are doing well and which are not? Where are the gaps and opportunities; what is driving the market? Which are the key playing fields? Which are the winning edge imperatives? How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what? 9

10 Disclaimer MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge when ordering that MarketsandMarkets strategic analysis services are for our customers internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Furthermore, no part may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the permission of the publisher. For information regarding permission, contact: Tel: Copyright 2010 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets. 10

11 About MarketsandMarkets We publish about 120 reports a Our clients value our reports year across 10 main industries. especially for the market insight The reports are exhaustive, we provide along with the market detailing about 50 micro markets n u m b e r s. O u r t e a m s o f and product segments, and specialized market analysts and featuring about 80 to 100 market domain experts work within a data summary tables, 50 short structured research process to company profiles, a five-level deliver well-analyzed market market breakdown, overviews of r e p o r t s t o F o r t u n e more than 300 patents, as well as companies globally. analyses of the strategic and competitive landscape. Click here to learn more about us Related Reports Global Oncology Pharmaceuticals and Therapeutics Market Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. Report code: PH 1114 Price: $4650 Global Weight Loss and Diet Management Market ( ) Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. Report code: PH 1001 Price: $4650 Autoimmune Treatment ( ) The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market. Report code: PH 1012 Price: $